Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
05.05.26
/
50%
€357.25
Target price
05.05.27
€527.05
Performance (%)
27.73%
Price
12.08.26
€456.30
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley currently has a performance of 27.73%. This prediction currently runs until 05.05.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 10.633% | 10.633% |
| iShares Core DAX® | 0,18 % | 5,07 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % |
| iShares S&P 500 | -0,17 % | 0,90 % |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (VRTX) had its "overweight" rating reaffirmed by Morgan Stanley. They now have a $616.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.55
10.04.26
10.04.26
€523.50
10.04.27
10.04.27
22.81%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€429.85
10.03.26
10.03.26
€512.68
10.03.27
10.03.27
6.15%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€420.00
13.02.26
13.02.26
-
13.02.27
13.02.27
8.64%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
21.39%
12.08.26
12.08.26